Organized by Deloitte, the 2023 "Deloitte Rising Star" selection event, after nearly half a year of evaluation and review, recently held a grand award ceremony.

Great Bay Bio was awarded the "2023 Deloitte Rising Star Award".

The "Deloitte Rising Star" selection project aims to recognize outstanding companies that have been established for a short period but have already achieved a leading position in their niche fields and have great growth potential. Many industry leaders have emerged from both projects' lists over the years, such as Tencent, JD.com, ByteDance, Mindray, SMIC, WuXi AppTec, Apple, Microsoft, and Tesla. The evaluation process has stringent review standards on the founding team, technological innovation, industry ranking, financing situation, and more.

Great Bay Bio's winning of this honor is a high recognition from Deloitte of Great Bay Bio's innovative strength, commercialization capability, and future growth potential. Great Bay Bio is the first to create "AI + Bioprocessing" in the world, dedicated to applying artificial intelligence platforms to promote innovations in bioprocessing technology. Several commercialized AI technology platforms have established long-term cooperation with leading companies both domestically and internationally, addressing many global challenges in drug development such as long timelines, high costs, and low success rates, including in fields like biopharmaceuticals, IVD, and synthetic biology.